Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
AJR Am J Roentgenol. 2011 Aug;197(2):510-5. doi: 10.2214/AJR.10.6029.
The purpose of this article was to compare periprocedural analgesic requirements and hospital length of stay for treatment of patients with painful metastatic tumors involving bone using either percutaneous radiofrequency ablation (RFA) or cryoablation.
A retrospective review was conducted of patients who underwent either imaging-guided cryoablation or imaging-guided RFA for painful metastatic tumors involving bone. The total analgesic usage for 24 hours after the procedure was expressed as a standard morphine-equivalent dose. Analgesic usage at admission served as a baseline for comparison. Total hospital stay was used as an additional measurement of procedure-related morbidity.
Fifty-eight patients underwent either cryoablation (n = 36) or RFA (n = 22) for painful metastatic tumors involving bone. Twenty-two primary tumors were treated. The most common treatment site was the pelvis (n = 31). There was no significant difference between the two groups with regard to tumor histologic type (p = 0.52) and location (p = 0.72). The median tumor diameter was 4.4 cm for the cryoablation group and 5.0 cm for the RFA group (p = 0.63). Pretreatment pain scores, measured on a scale of 0 to 10, were not significantly different between the two groups: 6.5 for cryoablation and 6.0 for RFA (p = 0.78). Analgesic use in the 24 hours immediately after the procedure decreased significantly by 24 morphine-equivalent doses after cryoablation, whereas it increased by a median of 22 morphine-equivalent doses after RFA (p = 0.03). Total hospital length of stay for patients undergoing cryoablation was a median of 2.5 days less than that for patients receiving RFA (p = 0.003).
The use of cryoablation compared with RFA is associated with a greater reduction in analgesic dose and shorter hospital stays after the procedure in the perioperative time frame.
本文旨在比较经皮射频消融(RFA)或冷冻消融治疗累及骨的疼痛性转移性肿瘤患者的围手术期镇痛需求和住院时间。
对接受影像引导下冷冻消融或 RFA 治疗累及骨的疼痛性转移性肿瘤的患者进行回顾性研究。将术后 24 小时内的总镇痛用量表示为标准吗啡等效剂量。入院时的镇痛用量作为比较的基线。总住院时间作为衡量与手术相关发病率的另一个指标。
58 例患者接受了冷冻消融(n = 36)或 RFA(n = 22)治疗累及骨的疼痛性转移性肿瘤。22 例为原发性肿瘤。最常见的治疗部位是骨盆(n = 31)。两组肿瘤组织学类型(p = 0.52)和位置(p = 0.72)无显著差异。冷冻消融组肿瘤直径中位数为 4.4cm,RFA 组为 5.0cm(p = 0.63)。两组术前疼痛评分(0-10 分)无显著差异:冷冻消融组为 6.5,RFA 组为 6.0(p = 0.78)。冷冻消融后,术后 24 小时内的镇痛用量减少了 24 个吗啡等效剂量,而 RFA 后则增加了中位数 22 个吗啡等效剂量(p = 0.03)。接受冷冻消融的患者总住院时间中位数比接受 RFA 的患者短 2.5 天(p = 0.003)。
与 RFA 相比,冷冻消融在围手术期内与更大的镇痛剂量减少和较短的住院时间相关。